secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001493152-26-009017
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Celularity CFO Joseph DosSantos departs; John Sprague named acting CFO
----------------------------------------------------------------------

- Joseph DosSantos left as SVP Finance and Acting CFO on Feb 27, 2026 for personal reasons.
- John Sprague appointed Acting CFO effective same date.
- No additional details on compensation or transition timeline provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000149315226009017/0001493152-26-009017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000149315226009017/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-009017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer